Paramount Cosmetics (India) (BSE 507970)₹35.40+4.98%Personal Care
In the Mar 2026 quarter (standalone), Paramount Cosmetics (India) reported sales of ₹2.80 Cr, down 53.3% from Mar 2025, and net profit of −₹0.06 Cr. For the year to Mar 2026, sales were ₹21.43 Cr and net profit ₹0.06 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.74 | 5.71 | 6.29 | 5.11 | 3.73 | 5.14 | 5.57 | 5.99 | 4.69 | 8.70 | 5.24 | 2.80 |
| Expenses | 4.23 | 6.04 | 5.93 | 5.10 | 3.41 | 4.80 | 5.20 | 5.92 | 4.23 | 8.25 | 5.00 | 2.32 |
| Operating Profit | 0.48 | −0.35 | 0.32 | −0.01 | 0.29 | 0.30 | 0.33 | 0.03 | 0.43 | 0.40 | 0.20 | 0.45 |
| OPM % | 10.4% | −6.3% | 5.3% | −0.4% | 8.1% | 6.1% | 6.2% | 0.7% | 9.4% | 4.8% | 4.0% | 16.6% |
| Other Income | 0.11 | 1.23 | 0.32 | 0.36 | 0.29 | 0.25 | 0.26 | 0.39 | 0.34 | 0.22 | 0.23 | 0.28 |
| Interest | 0.40 | 0.47 | 0.45 | 0.45 | 0.44 | 0.43 | 0.42 | 0.35 | 0.68 | 0.31 | 0.29 | 0.60 |
| Depreciation | 0.18 | 0.18 | 0.18 | 0.18 | 0.15 | 0.15 | 0.15 | 0.14 | 0.12 | 0.13 | 0.13 | 0.13 |
| Profit before tax | 0.06 | 0.26 | 0.06 | −0.27 | 0.04 | 0.02 | 0.07 | −0.04 | 0.02 | 0.23 | 0.06 | 0.05 |
| Tax % | 40.0% | 32.0% | 40.0% | −19.3% | 33.3% | −100.0% | 66.7% | −33.4% | 700.0% | 45.4% | 40.0% | 250.0% |
| Net Profit | 0.05 | 0.17 | 0.04 | −0.22 | 0.02 | 0.02 | 0.03 | −0.03 | −0.07 | 0.14 | 0.04 | −0.06 |
| EPS (Rs) | 0.09 | 0.34 | 0.07 | −0.44 | 0.03 | 0.03 | 0.05 | −0.05 | −0.13 | 0.28 | 0.07 | −0.11 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.14 | 34.93 | 21.02 | 21.89 | 24.21 | 17.52 | 20.22 | 26.77 | 21.85 | 20.42 | 21.43 | 21.43 |
| Expenses | 42.15 | 29.43 | 16.45 | 17.40 | 20.19 | 14.85 | 21.02 | 23.96 | 21.30 | 19.31 | 19.80 | 19.80 |
| Operating Profit | 6.71 | 5.30 | 4.46 | 4.37 | 3.90 | 2.58 | −0.91 | 2.64 | 0.41 | 0.98 | 1.51 | 1.48 |
| OPM % | 13.8% | 15.3% | 21.4% | 20.2% | 16.3% | 14.9% | −4.6% | 9.9% | 1.9% | 4.9% | 7.2% | 6.9% |
| Other Income | 0.25 | 0.06 | 0.35 | 0.04 | 0.03 | 1.16 | 4.55 | 0.19 | 2.08 | 1.22 | 1.10 | 1.07 |
| Interest | 3.04 | 3.24 | 2.83 | 2.51 | 2.26 | 2.32 | 2.36 | 1.71 | 1.75 | 1.61 | 1.84 | 1.88 |
| Depreciation | 2.54 | 2.15 | 1.73 | 1.44 | 1.26 | 1.07 | 0.96 | 0.82 | 0.68 | 0.56 | 0.47 | 0.51 |
| Profit before tax | 1.45 | 0.03 | 0.31 | 0.52 | 0.46 | 0.40 | 0.35 | 0.35 | 0.11 | 0.08 | 0.35 | 0.36 |
| Tax % | 45.2% | 600.0% | 90.0% | 125.5% | 128.9% | 10.2% | 41.2% | 38.3% | 80.0% | 57.1% | 82.4% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.01 | 0.00 | 1.01 | 0.00 | 0.00 | — |
| Net Profit | 0.81 | −0.10 | 0.05 | −0.14 | −0.13 | 0.35 | 0.21 | 0.22 | 0.03 | 0.04 | 0.06 | 0.05 |
| EPS (Rs) | 1.66 | −0.20 | 0.09 | −0.28 | −0.26 | 0.71 | 0.42 | 0.44 | 0.05 | 0.07 | 0.11 | 0.11 |
| Dividend payout % | 30.4% | −270.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.86 | 4.86 | 4.86 | 4.85 | 4.86 | 4.86 | 4.86 | 4.87 | 4.87 | 4.86 | 4.86 | 4.86 |
| Reserves | 18.61 | 19.11 | 16.85 | 16.60 | 14.59 | 14.47 | 14.61 | 14.88 | 15.33 | 15.42 | 15.48 | 15.59 |
| Borrowings | 23.25 | 24.09 | 20.82 | 20.58 | 20.82 | 18.16 | 17.23 | 14.58 | 12.52 | 12.20 | 11.39 | 2.39 |
| Other Liabilities | 17.45 | 16.85 | 8.72 | 5.39 | 7.85 | 11.62 | 11.59 | 12.95 | 10.19 | 8.32 | 8.67 | 12.24 |
| Total Liabilities | 64.17 | 64.91 | 51.25 | 47.42 | 48.12 | 49.11 | 48.29 | 47.28 | 42.91 | 40.80 | 40.40 | 35.08 |
| Fixed Assets | 25.24 | 23.82 | 22.20 | 20.51 | 19.33 | 18.15 | 17.24 | 16.36 | 15.67 | 14.73 | 14.18 | 13.78 |
| CWIP | 0.00 | 0.13 | 0.35 | 0.24 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 38.93 | 40.96 | 28.70 | 26.67 | 28.71 | 30.96 | 31.05 | 30.92 | 27.24 | 26.07 | 26.22 | 21.30 |
| Inventories | 16.99 | 20.75 | 16.45 | 17.20 | 17.45 | 15.71 | 16.31 | 14.84 | 13.18 | 16.95 | 21.23 | 18.73 |
| Trade receivables | 11.27 | 10.36 | 2.83 | 0.13 | 3.18 | 6.63 | 6.04 | 7.40 | 6.21 | 3.86 | 2.16 | 0.01 |
| Cash & equivalents | 2.57 | 0.95 | 0.90 | 1.15 | 0.76 | 0.88 | 0.72 | 0.85 | 0.56 | 1.49 | 1.46 | 1.50 |
| Total Assets | 64.17 | 64.91 | 51.25 | 47.42 | 48.12 | 49.11 | 48.29 | 47.28 | 42.91 | 40.80 | 40.40 | 35.08 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 7.20 | 0.40 | 6.46 | 3.80 | 4.42 | 4.26 | 2.28 | 0.83 | 3.66 | −0.25 | 1.41 | 10.80 |
| Cash from investing activity | −8.20 | 1.49 | −0.66 | 0.04 | −0.20 | 0.00 | 0.00 | 4.33 | 0.04 | 2.21 | 0.95 | 0.22 |
| Cash from financing activity | 1.22 | −3.52 | −5.80 | −3.62 | −4.47 | −4.18 | −2.23 | −5.04 | −4.06 | −2.07 | −2.42 | −10.88 |
| Net cash flow | 0.17 | −1.61 | 0.00 | 0.22 | −0.24 | 0.10 | 0.04 | 0.13 | −0.33 | −0.06 | −0.04 | 0.15 |
| Capex | 8.36 | 1.22 | 0.70 | 0.04 | 0.22 | 0.07 | 0.13 | 0.26 | 0.10 | 0.01 | 0.00 | 0.05 |
| Free cash flow | −1.21 | 1.63 | 5.74 | 3.75 | 4.19 | 4.25 | 2.14 | 5.16 | 3.55 | 1.06 | 1.41 | 10.74 |
| CFO / OP % | 146.0% | 6.0% | 134.0% | 95.0% | 103.0% | 108.9% | 87.9% | −95.1% | 139.9% | −57.0% | 140.9% | 757.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 84 | 76 | 29 | 1 | 52 | 99 | 125 | 133 | 84 | 64 | 38 | 0 |
| Inventory days | 197 | 255 | 365 | 1,473 | 1,346 | 1,030 | 1,959 | 874 | 396 | 399 | 594 | 448 |
| Days payable | 139 | 146 | 108 | 135 | 265 | 171 | 411 | 227 | 77 | 48 | 50 | 30 |
| Cash conversion cycle | 143 | 186 | 286 | 1,340 | 1,134 | 960 | 1,675 | 782 | 404 | 416 | 583 | 418 |
| Working capital days | 60 | 78 | 57 | 95 | 14 | 7 | 51 | 87 | 76 | 149 | 153 | 156 |
| ROCE % | 9.9% | 9.5% | 7.2% | 7.4% | 7.4% | 7.0% | 7.3% | −4.8% | 6.1% | 2.5% | 5.2% | 8.0% |
For the Mar 2026 quarter, Paramount Cosmetics (India) reported sales of ₹2.80 Cr, down 53.3% year on year and net profit of −₹0.06 Cr. The operating margin was 16.6%.
Paramount Cosmetics (India)'s sales for the year to Mar 2026 were ₹21.43 Cr; over the last twelve months they were ₹21.43 Cr.
Net profit for the year to Mar 2026 was ₹0.06 Cr, and ₹0.05 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.11.
Paramount Cosmetics (India) reported borrowings of ₹2.39 Cr at Mar 2026, against cash and equivalents of ₹1.50 Cr.
Cash from operations was ₹10.80 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹10.74 Cr.